207 related articles for article (PubMed ID: 19109555)
1. ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.
Collins NB; Wilson JB; Bush T; Thomashevski A; Roberts KJ; Jones NJ; Kupfer GM
Blood; 2009 Mar; 113(10):2181-90. PubMed ID: 19109555
[TBL] [Abstract][Full Text] [Related]
2. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
Zhu W; Dutta A
Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
[TBL] [Abstract][Full Text] [Related]
3. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
Ho GP; Margossian S; Taniguchi T; D'Andrea AD
Mol Cell Biol; 2006 Sep; 26(18):7005-15. PubMed ID: 16943440
[TBL] [Abstract][Full Text] [Related]
5. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner.
Qiao F; Moss A; Kupfer GM
J Biol Chem; 2001 Jun; 276(26):23391-6. PubMed ID: 11297559
[TBL] [Abstract][Full Text] [Related]
6. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways.
Taniguchi T; Garcia-Higuera I; Xu B; Andreassen PR; Gregory RC; Kim ST; Lane WS; Kastan MB; D'Andrea AD
Cell; 2002 May; 109(4):459-72. PubMed ID: 12086603
[TBL] [Abstract][Full Text] [Related]
7. A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.
Yagasaki H; Adachi D; Oda T; Garcia-Higuera I; Tetteh N; D'Andrea AD; Futaki M; Asano S; Yamashita T
Blood; 2001 Dec; 98(13):3650-7. PubMed ID: 11739169
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
[TBL] [Abstract][Full Text] [Related]
9. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
10. Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors.
Landais I; Hiddingh S; McCarroll M; Yang C; Sun A; Turker MS; Snyder JP; Hoatlin ME
Mol Cancer; 2009 Dec; 8():133. PubMed ID: 20043851
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of fanconi anemia (FA) complementation group G protein, FANCG, at serine 7 is important for function of the FA pathway.
Qiao F; Mi J; Wilson JB; Zhi G; Bucheimer NR; Jones NJ; Kupfer GM
J Biol Chem; 2004 Oct; 279(44):46035-45. PubMed ID: 15299017
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of serines 635 and 645 of human Rad17 is cell cycle regulated and is required for G(1)/S checkpoint activation in response to DNA damage.
Post S; Weng YC; Cimprich K; Chen LB; Xu Y; Lee EY
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):13102-7. PubMed ID: 11687627
[TBL] [Abstract][Full Text] [Related]
13. The Fanconi anemia protein FANCM is controlled by FANCD2 and the ATR/ATM pathways.
Sobeck A; Stone S; Landais I; de Graaf B; Hoatlin ME
J Biol Chem; 2009 Sep; 284(38):25560-8. PubMed ID: 19633289
[TBL] [Abstract][Full Text] [Related]
14. Fanconi anemia complementation group A (FANCA) localizes to centrosomes and functions in the maintenance of centrosome integrity.
Kim S; Hwang SK; Lee M; Kwak H; Son K; Yang J; Kim SH; Lee CH
Int J Biochem Cell Biol; 2013 Sep; 45(9):1953-61. PubMed ID: 23806870
[TBL] [Abstract][Full Text] [Related]
15. A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair.
Tomida J; Itaya A; Shigechi T; Unno J; Uchida E; Ikura M; Masuda Y; Matsuda S; Adachi J; Kobayashi M; Meetei AR; Maehara Y; Yamamoto K; Kamiya K; Matsuura A; Matsuda T; Ikura T; Ishiai M; Takata M
Nucleic Acids Res; 2013 Aug; 41(14):6930-41. PubMed ID: 23723247
[TBL] [Abstract][Full Text] [Related]
16. A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G; Naf D; Garcia-Higuera I; Wasik J; Cheng A; Yamashita T; Tipping A; Morgan N; Mathew CG; D'Andrea AD
Exp Hematol; 1999 Apr; 27(4):587-93. PubMed ID: 10210316
[TBL] [Abstract][Full Text] [Related]
17. ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions.
Singh TR; Ali AM; Paramasivam M; Pradhan A; Wahengbam K; Seidman MM; Meetei AR
Cancer Res; 2013 Jul; 73(14):4300-10. PubMed ID: 23698467
[TBL] [Abstract][Full Text] [Related]
18. Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex.
Noll M; Battaile KP; Bateman R; Lax TP; Rathbun K; Reifsteck C; Bagby G; Finegold M; Olson S; Grompe M
Exp Hematol; 2002 Jul; 30(7):679-88. PubMed ID: 12135664
[TBL] [Abstract][Full Text] [Related]
19. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
[TBL] [Abstract][Full Text] [Related]
20. [FANCA gene mutation analysis in Fanconi anemia patients].
Chen F; Peng GJ; Zhang K; Hu Q; Zhang LQ; Liu AG
Zhonghua Xue Ye Xue Za Zhi; 2005 Oct; 26(10):616-8. PubMed ID: 16532972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
